Derrick Rowe, Chairman, Bluedrop
Whether you’re seeking to grow your business, transfer ownership to the next generation or simply secure a cushion against market uncertainties, Grenville can help.Learn More
Unlike traditional capital sources Grenville's revenue-based finance approach retains your freedom to do what you do best – manage and grow your companies.Learn More
September 16, 2014
Grenville Strategic Royalty Corp. (TSXV: GRC) (“Grenville”) is pleased to announce that it has contracted for a gross sales royalty from Lattice Biologics Inc. (“Lattice Biologics”) in exchange for an advance of USD$2 million.